Literature DB >> 16046033

[Cerebral venous thrombosis].

I Crassard1, M-G Bousser.   

Abstract

INTRODUCTION: Although more rare than arterial thrombosis, cerebral venous thrombosis are a non-negligible cause of stroke. Characterised by the large diversity of clinical presentations and etiologies, they have a much better prognosis than arterial stroke. The evolution remains unforeseeable, with a non-negligible proportion of worsening at the acute phase and diagnosis must be early to begin as soon as possible the treatment, which is at present based on heparin therapeutics. CURRENT KNOWLEDGE AND KEY POINTS: Neuroimaging examinations are essential for diagnosis of CVT. MR Imaging with MR venography is the key procedure. New sequences are on evaluation in CVT bringing some physiopathogical arguments (Diffusion weighted imaging) or help for diagnosis (with T2* MRI sequence). If D-dimers dosage is helpful for diagnosis of deep venous thrombosis, its interest remains to be determined during CVT.
CONCLUSION: CVT diagnosis is a challenge for the clinician. Because of the multiple causes and favorising factors, CVT are at the convergence of many specialties and could thus benefit of each one contribution for better understanding the physiopathology, improving earlier diagnosis or identifying the severe forms that could require right away more aggressive treatments than heparin. The interest of local thrombolysis or thrombectomy remains to be determined in an international randomised study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046033     DOI: 10.1016/j.revmed.2005.06.003

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Evaluation of cerebral venous thrombosis secondary to oral contraceptive use in adolescents.

Authors:  Hasan H Özdemir; Sefer Varol; Eşref Akıl; Abdullah Acar; Caner F Demir
Journal:  Neurol Sci       Date:  2014-08-05       Impact factor: 3.307

2.  Cerebral venous thrombosis associated with homozygous factor V Leiden mutation in a 15-year-old girl of Tunisian origin.

Authors:  Olfa Ben Salem-Berrabah; Nejiba Fekih-Mrissa; Samy Laayouni; Nasreddine Gritli; Ridha Mrissa
Journal:  Ann Saudi Med       Date:  2011 Nov-Dec       Impact factor: 1.526

3.  [Subarachnoid hemorrhage and parenchymal hematoma revealing a cerebral venous thrombosis].

Authors:  Toufik Joulali; Ali Derkaoui; Sophia Besri; Mohammed Malki; Abdelkarim Shimi; Mohammed Khatouf
Journal:  Pan Afr Med J       Date:  2015-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.